U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
Source: US Top News and Analysis
Related Posts
How Jared Kushner Turned White House Access Into a Billion-Dollar Saudi Payday
A 34-year-old marketing manager in Chicago says she was denied a long-awaited promotion last month—not…
White House launches app touting Trump’s record, with some key omissions
The app includes a link to report tips to Immigrations and Customs Enforcement. Source: US…
Epstein victims sue Google, Trump administration for disclosing personal information
A lawsuit filed in Northern California alleges that Google’s AI features generated contact information for…